Study Objectives: Screening patients for critical illness is a cornerstone of care for sepsis patients in the emergency department (ED). We previously showed that the quick Sepsis related Organ Failure Assessment (qSOFA) criteria thresholds had slightly better ED-centered screening performance for early critical illness than traditional systemic inflammatory response syndrome (SIRS)/ sepsis criteria and lactate levels. Yet, with relatively low sensitivity (86%), qSOFA criteria may still miss a substantial number of patients when used alone for critical illness screening. Our objective was to determine whether combinations of lactate levels and qSOFA thresholds have better screening test performance characteristics than isolated lactate levels and qSOFA thresholds for predicting the need for critical care and mortality within the first 72 hours of hospital admission.
Methods: This was a planned secondary analysis of a retrospective cohort study of consecutive adult patients from 3 academic and 2 community hospitals who were admitted from their EDs with infectious disease-related illness. We recorded qSOFA criteria and lactate levels in the first 6 hours of ED stay. Our primary outcome, defined as "critical illness," was a composite of hospital death, vasopressor use, and intensive care unit stay within 72 hours of presentation. We determined screening performance parameters (sensitivity, specificity, positive and negative predictive value) of the following: (1) lactate 2, lactate 4; (2) qSOFA 1, 2 and ¼3; (3) combinations of lactate levels AND qSOFA thresholds; and (4) permutations of lactate levels OR qSOFA thresholds.
Results: Of 3743 enrolled patients, 2584 had a lactate drawn within the first 6 hours of ED stay and 465 (18.0%) had the primary composite outcome. Regarding criteria thresholds, 1751 (67.8%) and 888 (34.4%) met sepsis and severe sepsis criteria, respectively. The qSOFA scores were >1, >2, and ¼ 3 in 1530 (59.2%), 569 (22.0%), and 137 (5.3%) patients, respectively, and 888 (34.4%) had a lactate level 2 and 205 (7.9%) had a lactate level 4. The combination of qSOFA 1 OR Lactate 2 had the highest sensitivity at 94.0% (95% CI: 91.3 to 95.9) but the lowest specificity at 37.5% (95% CI: 35.5 to 39.6) compared to either criterion alone and any other combination. The combination of qSOFA ¼3 AND Lactate 4 had the highest specificity at 99.7% (95% CI: 99.3 to 99.9) but the lowest sensitivity at 7.1% (95% CI: 5.0 to 9.9) compared to either criterion alone and any other combination. See Study Objectives: We aimed to compare the diagnostic performances of presepsin with procalcitonin (PCT), the leading biomarker for sepsis at present, as well as other hot-studied biomarkers from 2 perspectives: diagnosis of sepsis (Sepsis 3.0) and differentiation of infectious from non-infectious systemic inflammatory response syndrome (SIRS).
Methods: A comprehensive systematic review until February 2018 was conducted for 7 biomarkers targeting at 2 perspectives. For each perspective, a network meta-analysis for diagnostic tests and 2 meta-analyses were implemented. Investigation into sources of heterogeneity was conducted with meta-regressions and subgroup analyses. Estimations of optimal cutoffs were provided with meta-regressions after adjusting potential sources of heterogeneity.
Results: A total of 108 studies representing 14,555 patients were included partially with risks of bias or suboptimal applicability. From both networks of comparisons targeting to different perspectives, presepsin displayed outstanding sensitivity among 7 biomarkers (Figure) . Besides, more confident estimations were obtained from network meta-analyses for diagnostic tests comparing to conventional meta-analyses. When comparing presepsin to PCT, 0.13 (95% CI: [0.04, 0.19] ) higher sensitivity with significance and 0.09 (95% CI: [-0.02,0.22] ) lower specificity were suggested for diagnosis of sepsis (Sepsis 3.0). For differentiation of infectious SIRS, 0.09 (95% CI: [-0.03,0.14]) higher sensitivity with significance and similar specificity 0.01 (95% CI: [-0.04,0 .09]) were suggested. Significant heterogeneities without threshold effect were consistently detected for all biomarkers, and the subsequent investigations into which suggested specimen type and countries study conducted as significant sources of heterogeneity. Optimal cutoffs were evaluated with meta-regressions after adjusting potential sources of heterogeneity, which suggested 600-700 pg/mL and 1.5-2 ng/mL for presepsin and PCT, respectively.
Conclusions: Presepsin outperformed PCT and other hot-studied biomarkers in both diagnosis of sepsis as well as differentiation of infectious SIRS. In addition, incorporated with indirect evidences, more confidence was gained from network meta-analyses for diagnostic tests than conventional meta-analyses. However, further investigation into sources of heterogeneity is still suggested.
